Literature DB >> 16286890

Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects.

Stefanie Weber1, Burkhard Tönshoff.   

Abstract

Focal segmental glomerulosclerosis (FSGS) is the primary renal disease in approximately one-tenth of pediatric patients receiving a renal allograft. Recurrence of proteinuria after renal transplantation is observed in approximately 30% of patients and negatively impacts graft survival. Risk factors for recurrence are a chronological age <15 years at onset of the nephrotic syndrome and a rapid progression of the disease in the native kidneys leading to end-stage renal disease in less than 3 years. Mesangial proliferation in the native kidneys is also an important negative predictive factor for disease recurrence. With rapid recurrence of FSGS and loss of the allograft, further renal transplants also carry a high likelihood of FSGS recurrence. Different pathogenic factors have been discussed for the recurrence of proteinuria/FSGS in the transplanted kidney, especially the involvement of a proteinuric circulating factor, whose production seems to follow T-cell dysfunction. In the last decade, mutations in genes encoding podocyte proteins have been identified in different forms of hereditary FSGS. Mutations of NPHS2 were detected in 26-38% of familial autosomal recessive steroid-resistant NS (SRNS), 6-19% of sporadic cases of SRNS, and in few adult patients with FSGS. Large multicenter studies demonstrated that patients with two pathogenic NPHS2 mutations have a very low risk of recurring FSGS after renal transplantation, whereas patients with only one mutation presumably have a risk comparable to non-NPHS2 FSGS patients. The management of FSGS following renal transplantation remains controversial. Following the assumption of a putative permeability factor, several studies have suggested the efficacy of plasmapheresis in inducing remission, preferably in conjunction with high-dose cyclosporine A or cyclophosphamide. Prospective studies will be necessary to better evaluate different therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286890     DOI: 10.1097/01.tp.0000187110.25512.82

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  21 in total

1.  Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.

Authors:  Britta Höcker; Tanja Knüppel; Rüdiger Waldherr; Franz Schaefer; Stefanie Weber; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

2.  Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.

Authors:  Thomas M Kitzler; Nadezda Kachurina; Martin M Bitzan; Elena Torban; Paul R Goodyer
Journal:  Pediatr Nephrol       Date:  2018-07-07       Impact factor: 3.714

Review 3.  Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation.

Authors:  David K C Cooper; Martin Wijkstrom; Sundaram Hariharan; Joshua L Chan; Avneesh Singh; Keith Horvath; Muhammad Mohiuddin; Arielle Cimeno; Rolf N Barth; John C LaMattina; Richard N Pierson
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

Review 4.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

Review 5.  Extrarenal determinants of kidney filter function.

Authors:  Eunsil Hahm; Vasil Peev; Jochen Reiser
Journal:  Cell Tissue Res       Date:  2017-05-30       Impact factor: 5.249

6.  Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.

Authors:  Gabriel M Cara Fuentes; Carmen Garcia Meseguer; Antonia Peña Carrion; Marta Melgosa Hijosa; Araceli Garcia-Pose; Angel Alonso Melgar; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2009-12-03       Impact factor: 3.714

7.  Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation.

Authors:  B I Freedman; S K Nagaraj; J-J Lin; M D Gautreaux; D W Bowden; S S Iskandar; R J Stratta; J Rogers; E L Hartmann; A C Farney; A M Reeves-Daniel
Journal:  Am J Transplant       Date:  2009-10       Impact factor: 8.086

Review 8.  The expanding phenotypic spectra of kidney diseases: insights from genetic studies.

Authors:  Marijn F Stokman; Kirsten Y Renkema; Rachel H Giles; Franz Schaefer; Nine V A M Knoers; Albertien M van Eerde
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

Review 9.  Renal transplantation in human immunodeficiency virus (HIV)-positive children.

Authors:  Mignon I McCulloch; Udai K Kala
Journal:  Pediatr Nephrol       Date:  2014-04-02       Impact factor: 3.714

Review 10.  Disease recurrence in paediatric renal transplantation.

Authors:  Pierre Cochat; Sonia Fargue; Guillaume Mestrallet; Therese Jungraithmayr; Paulo Koch-Nogueira; Bruno Ranchin; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2009-02-27       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.